Baker Bros. Buys $35.02 Million of Madrigal Pharmaceuticals Stock, Reports 9.99% Stake
Funds advised by Baker Bros. Advisors LP bought 91,806 shares of Madrigal Pharmaceuticals common stock for $35,023,032 on Nov. 4 and Nov. 6, 2026, according to a Form 4 filed Friday.
The filing shows 15,666 shares bought Nov. 4 for $5.76 million, at weighted-average prices of $366.9922 and $368.1134 per share. A further 76,140 shares were bought Nov. 6 for $29.26 million, at weighted-average prices of $383.015, $388.29 and $396.61.
After the transactions, the filing reports 2,040,682 shares of common stock in the ownership column.
A Schedule 13D amendment filed the same day says Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker and Felix J. Baker beneficially own 2,330,144 Madrigal shares, or 9.99%. The percentage is based on 23,229,561 shares outstanding as of Oct. 29, 2026, plus 90,417 shares issuable on exercise of prefunded warrants and 4,790 vested stock options, according to the filing.
Baker Bros. said the amendment was filed to report purchases that resulted in a change of more than 1% in beneficial ownership, and that the funds hold the securities for investment purposes.
Sources
- Madrigal Form 4 filed by Baker Bros. Advisors LP and related reporting persons, filed Nov. 6, 2026 (accession 0001193125-26-452132)
- Madrigal Schedule 13D/A (Amendment No. 5), filed Nov. 6, 2026 (accession 0001104659-26-124003)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence. SI may make mistakes.